ESCALON MEDICAL CORP (ESMC) — SEC Financial Statements & Analysis

ESCALON MEDICAL CORP (ESMC) is a electromedical & electrotherapeutic apparatus company, incorporated in PA. ESCALON MEDICAL CORP trades on OTC as: ESMC. ESCALON MEDICAL CORP (ESMC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-15. Based on that filing, ESCALON MEDICAL CORP carries a market cap of $1.33M, a P/E ratio of 0.75x, a P/B ratio of 0.32x, a P/S ratio of 0.12x, an enterprise value of $-2.00M, and an EV/EBITDA multiple of 2.31x. On profitability, it posts a gross margin of 41.48%, an operating margin of -7.82%, a net margin of 15.61%, a Return on Equity (ROE) of 55.49%, a Return on Assets (ROA) of 28.04%, and a Return on Invested Capital (ROIC) of -65.66%. Per share, it reports EPS of $0.24, diluted EPS of $0.12, free cash flow per share of $-0.02, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 20.78% year-over-year, net income growth of 2302.85% year-over-year, and EPS growth of 2302.85% year-over-year. On the balance sheet, it maintains a current ratio of 2.59x, a quick ratio of 1.94x, working capital of $4.03M, a debt-to-equity ratio of 0.82x, a debt ratio of 0.45, an interest coverage ratio of -55.03x, free cash flow of $-143.97K (TTM), and net debt of $-3.34M. Figures sourced from SEC EDGAR.

Market Cap

$1.33M

P/E TTM

0.75x

EPS TTM

$0.24

P/B TTM

0.32x

ROE TTM

55.49%

ROA TTM

28.04%

Debt To Equity

0.82x

Free Cash Flow TTM

$-143.97K

Net Revenue TTM Growth 1Y

20.78%

Data as of 2026-03-31 · Source: SEC EDGAR